Actualizado 04/12/2008 08:32
- Comunicado -

European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patient

    
    Roche Group Media Office:
    
    Phone: +41-61-688-8888 / Email: basel.mediaoffice@roche.com
    
    - Elina Ämmälä
    - Daniel Piller (Head)
    - Alexander Klauser
    - Martina Rupp
    - Claudia Schmitt

Roche Group Media Office: Phone: +41-61-688-8888 / Email: basel.mediaoffice@roche.com

Contenido patrocinado